Trial intelligence / Profile preview

Phenylephrine ER for Nasal Congestion in Allergic Rhinitis

NCT01413958Phase 3Completed

Sponsor
Bayer
Start
Aug 2011
Primary completion
Oct 2011
Modality
Small Molecules
01

Overview

A Phase 3 trial of phenylephrine in seasonal allergic rhinitis (SAR), sponsored by Bayer. Started Aug 2011; status: completed.

02

Drugs

phenylephrine
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT01413958.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01413958.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call